Online citations, reference lists, and bibliographies.
← Back to Search

The Incidence Of Lynch Syndrome

A. Chapelle
Published 2004 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Lynch syndrome (LS) here is defined as carriership of a deleterious mismatch repair (MMR) gene mutation. By screening for MMR gene mutations in unselected colorectal or endometrial cancer patients, it was found that the prevalence of LS in colorectal and endometrial cancer patients is 1–3%. On extrapolation to the entire population, the incidence of LS is between 1:2000 and 1:660. As all screening methods are less than 100% sensitive, the above figures are underestimates.
This paper references
10.1001/JAMA.282.3.247
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing.
S. Syngal (1999)
10.1056/NEJMRA012242
Hereditary colorectal cancer.
H. Lynch (1991)
10.1053/GAST.2001.28634
HNPCC: an uncommon but important diagnosis.
J. Terdiman (2001)
10.1038/nrc1453
Genetic predisposition to colorectal cancer
A. Chapelle (2004)
Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry.
M. Ponz de Leon (1989)
10.1038/NG0997-79
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC
S. Laken (1997)
10.1200/JCO.2002.20.4.897
Microsatellite instability phenotype of tumors: genotyping or immunohistochemistry? The jury is still out.
A. Chapelle (2002)
10.1038/ng1374
The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer
S.М. Lipkin (2004)
10.1200/JCO.2001.19.19.3944
Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study.
A. Percesepe (2001)
10.1007/BF02054116
Frequency of hereditary nonpolyposis colorectal cancer
Jukka‐Pekka Mecklin (1995)
10.1038/ng1342
Germline epimutation of MLH1 in individuals with multiple cancers
C. Suter (2004)
10.1053/GAST.2002.32537
Hereditary nonpolyposis colorectal cancer in young colorectal cancer patients: high-risk clinic versus population-based registry.
J. Terdiman (2002)
The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study
P Peltomäki (1997)
10.1053/GAST.1997.V113.PM9322509
Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer.
P. Peltomäki (1997)
10.1073/pnas.1030231100
Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers
P. Goodfellow (2003)
10.1053/GAST.2001.20874
Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing.
J. Terdiman (2001)
Proof of ‘‘disease causing’
RG Cotton (1998)
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
C. Boland (1998)
10.1136/JMG.37.7.533
Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population.
M. Ravnik-Glavač (2000)
10.1016/0016-5085(87)90565-8
Frequency of hereditary colorectal carcinoma.
J. Mecklin (1987)
10.1086/323658
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.
J. Cunningham (2001)
10.1200/JCO.2004.99.271
TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies.
B. Pasche (2004)
10.1053/GAST.2001.27996
The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer.
W. Samowitz (2001)
10.1200/JCO.20.4.1043
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.
N. Lindor (2002)
10.1093/JNCI/93.9.716
Re: Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases.
D. Evans (2001)
10.1200/jco.2002.20.4.897
Microsatellite instability phenotype of tumors: genotyping or immunohistochemistry? The jury is still out.
A. Delachapelle (2002)
Case report on hereditary non-polyposis colon cancer (HNPCC) in Nigeria.
C. Adebamowo (2000)
10.1007/BF01296813
Frequency of hereditary nonpolyposis colorectal cancer in southern Alberta
P. Westlake (2005)
10.1016/S0016-5085(99)70510-X
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.
H. Vasen (1999)
10.1002/1097-0142(19930601)71:11<3493::AID-CNCR2820711106>3.0.CO;2-H
Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6‐year experience of a population‐based registry
Maurizio Ponz de Leòn (1993)
10.1002/(SICI)1098-2388(200006)18:4<305::AID-SSU5>3.0.CO;2-A
Hereditary nonpolyposis colorectal cancer.
H. Lynch (2000)
10.1136/gut.32.5.509
How prevalent is cancer family syndrome?
F. Kee (1991)
10.1016/0165-4608(91)90093-A
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, Part I.
H. Lynch (1991)
Identifica - tion of hereditary nonpolyposis colorectal
M PonzdeLeon
10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M
Proof of “disease causing” mutation
R. Cotton (1998)
10.1007/BF02053699
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
H. Vasen (1991)
in the general population . The 6 - year experience of a population - based registry
JP Mecklin (1993)
10.1073/pnas.2132286100
A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2
G. Wiesner (2003)
10.1056/NEJM199805213382101
Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
L. Aaltonen (1998)
Genomic medicine: Hereditary colon cancer
HT Lynch (2003)
10.1093/JNCI/92.18.1517
Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases.
D. Peel (2000)
A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden.
L. Aaltonen (1994)
10.1016/S0016-5085(00)70168-5
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H. Järvinen (2000)
10.1158/0008-5472.CAN-03-2879
Mismatch Repair Gene PMS2
H. Nakagawa (2004)
10.1200/JCO.2000.18.11.2193
Population-based molecular detection of hereditary nonpolyposis colorectal cancer.
R. Salovaara (2000)



This paper is referenced by
10.1186/s13045-017-0523-y
Association of a novel point mutation in MSH2 gene with familial multiple primary cancers
H. Hu (2017)
Genes de susceptibilidad al cáncer colorrectal hereditario, análisis en familias gallegas con poliposis colónica y sospecha de Síndrome de Lynch
N. Fernández (2011)
Mismatch Repair Deficient Cancer Diagnostic Aspects in Colorectal Cancer and the Role of Urological Cancer in Lynch Syndrome
P. Joost (2015)
10.1016/j.hoc.2010.08.011
Mouse models of inherited cancer syndromes.
Sohail Jahid (2010)
10.1186/1897-4287-10-6
Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations
Katarina Bartuma (2012)
10.1038/gim.2015.166
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
L. Susswein (2016)
10.1016/J.MRREV.2007.07.001
Etiologic impact of known cancer susceptibility genes.
K. Hemminki (2008)
Genética del carcinoma colorrectal con agregación familiar, en una muestra de la Región Andina colombiana
M. Lozano (2019)
10.1157/13098298
Genética del cáncer colorrectal y poliposis
F. B. Prunés (2006)
10.1016/j.bpobgyn.2016.10.017
Hereditary Ovarian Cancer and Risk Reduction.
L. Andrews (2017)
10.1007/978-3-319-43217-5_4
Are There Risk Factors in the European Population, Which Promote Rectal Cancer and/or Favour Curability?
J. Borràs (2018)
Towards improved detection and management of Lynch Syndrome
Dewkoemar Ramsoekh (2009)
10.1007/s10689-010-9373-2
Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry
Felipe Carneiro da Silva (2010)
10.1007/s10689-012-9547-1
Aberrant splicing caused by a MLH1 splice donor site mutation found in a young Japanese patient with Lynch syndrome
M. Takahashi (2012)
10.1111/j.1399-0004.2011.01802.x
Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation
S. Stuckless (2012)
Risk Factors and Variations in Global Occurrence of Endometrial Cancer
S. Chhabra (2019)
Genetic basis of hereditary colorectal cancers : Hereditary nonpolyposis colorectal cancer and Familial adenomatous polyposis
E. Renkonen (2006)
10.1136/jmg.2008.059311
Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients
J. Balmaña (2008)
10.1097/GIM.0b013e318220aaba
Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time
J. Berg (2011)
Tier 1 Genomic Applications: A Kentucky State Needs Assessment
Andrea L. Durst (2015)
Mismatch repair protein-dependent cytotoxic signaling in cells treated with the cancer chemotherapeutic cisplatin
Ryan P Topping (2009)
10.26182/5c9440df4629f
Screening for Lynch Syndrome in the Saudi population
Masood Alqahtani (2019)
10.1186/bcr3405
Risk of breast cancer in Lynch syndrome: a systematic review
Aung Ko Win (2012)
JORNADA DE ACTUALIZACIÓN EN GASTROENTEROLOGÍA APLICADA
F. B. Prunés (2016)
10.1074/jbc.M111.297523
Human MSH2 (hMSH2) Protein Controls ATP Processing by hMSH2-hMSH6*
C. Heinen (2011)
10.1111/his.12590
The pathology of hereditary polyposis syndromes
M. Novelli (2015)
10.2353/JMOLDX.2007.060170
Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.
S. Ogino (2007)
10.1016/j.gde.2010.03.001
The inherited genetics of ovarian and endometrial cancer.
S. Gayther (2010)
Mutation carriers’ perspectives on Lynch syndrome
H. V. Petersen (2013)
10.1016/j.canep.2009.06.007
An effect from anticipation also in hereditary nonpolyposis colorectal cancer families without identified mutations.
S. Timshel (2009)
10.1016/j.cgh.2018.04.025
Worldwide Practice Patterns in Lynch Syndrome Diagnosis and Management, Based on Data From the International Mismatch Repair Consortium
J. Pan (2018)
10.1016/j.biopha.2016.07.015
HMSH2 and HMSH6 gene expression profiles in colorectal adenocarcinoma in patients up to 50 years of age.
D. Germini (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar